Advertisement

Fred R. Hirsch, MD, PhD, Named Executive Director of New Center for Thoracic Oncology at Mount Sinai


Advertisement
Get Permission

Fred R. Hirsch, MD, PhD

Fred R. Hirsch, MD, PhD

Fred R. Hirsch, MD, PhD, an authority on lung cancer treatment and research, has joined Mount Sinai Health System as Executive Director of the newly created Center for Thoracic Oncology in The Tisch Cancer Institute at Mount Sinai and will also serve as the Richard M. Stein, MD, Joe Lowe, and Louis Price Professor of Medicine at the Icahn School of Medicine at Mount Sinai. In addition, Dr. Hirsch will be Associate Director of Biomarker Discovery for The Tisch Cancer Institute.

Dr. Hirsch’s career in lung cancer research spans more than 25 years and includes translational research, targeted therapies, and early detection of lung cancer. His research has helped identify and validate prognostic markers for lung cancer outcomes and biomarkers for personalized lung cancer therapies.

The new Center will give patients with lung cancer access to fully coordinated care that provides all the needed services—screening, diagnostics, pharmaceutical, surgical, nutrition, psychological, and social supportive services—for the best possible outcome. Patient care will be seamless to make treatment as easy as possible. The Center will expand Mount Sinai’s lung cancer screening program. Patients will also have access to the latest research and clinical trials to give them the highest-quality personalized care available.

William Oh, MD

William Oh, MD

“Mount Sinai is poised to make major advances in the early diagnosis of lung cancer and to better treat advanced disease, in particular by understanding how to harness the immune system to attack cancer cells,” said William Oh, MD, Chief of Hematology and Medical Oncology and Deputy Director of The Tisch Cancer Institute at Mount Sinai and the Ezra M. Greenspan, MD, Professor in Clinical Cancer Care Therapeutics.

More About Dr. Hirsch

Dr. Hirsch comes to Mount Sinai from the University of Colorado School of Medicine in Denver, where he was Associate Director for the University of Colorado Cancer Center and Professor of Medicine and Pathology. While there, he was Chief Executive Officer of the International Association for the Study of Lung Cancer.

Dr. Hirsch, who has published about 400 peer-reviewed scientific articles, has served on the National Cancer Institute’s Steering Committee for Thoracic Malignancies Program and is currently Co-Chair for Southwest Oncology Group’s Lung Cancer Translational Research Committee. 


Advertisement

Advertisement



Advertisement